SlideShare a Scribd company logo
FDA Warning Letters Study 
A Look at Warning Letters for Pharma/Biotech, Medical Device, 
and Food & Beverage Industries Since 2007 
A Warning Letter is official correspondence that notifies the highest-ranking known official of a regulated company 
that a serious violation of organizational regulations has been committed. These letters are published on the FDA 
website and are available for review by other government agencies, businesses, consumers, and the media.
FDA Warning Letters Issued by Year 
The average growth rate for warning letters issued between 2007 and 2012 was 15.8% per year. The issuing of 
FDA Warning Letters increased 78% from 2007 to 2013, even with a 12.4% decrease from 2012 to 2013. 
2007–2012 
We wanted to understand: What industries 
contributed the most to the increase and why? 
2012–June 30, 2014 
We believe the decrease was due to fewer FDA inspections 
as a result of reduced funding for the FDA1 and an industry-wide 
freeze on manufacturers’ FDA fees. 
1. http://www.politico.com/story/2013/02/fda-commissioner-margaret-hamburg-2013-budget-cuts-mean-less-safe-food-88241.html 
27.5% 
Decreased by 
comparing the first 
6 months of 2013 to the first 
6 months of 2014 
12.4% 
Decreased by 
from 2012 to 2013 
104% 
Total increase of 
from 2007 to 2012 
Increased by an average of 
per year (2007 to 2012) 
15.8%
Since FDA warning letters are made available to 
the public, we did some digging to find which 
industries accounted for the highest number of 
warning letters. Three industries comprised 95.72% 
of all FDA warning letters that were received 
between 2007 and 2013. 
Pharmaceutical/Biotechnology 
Medical Device 
Food & Beverage 
Industry Comparison 
Tobacco 
Consumer 
Products 
Pharmaceutical/ 
Biotechnology Food & Beverage 
Medical Device
In 2009, FDA warning letters to Pharma/Biotech companies increased 
by 48.59%. The following areas accounted for the increase (actual 
numbers): 
Pharmaceutical/ 
Biotechnology 
2007 
0 
50 
100 
150 
200 
250 
2008 2009 2010 2011 2012 2013 
1. http://eng.sfda.gov.cn/WS03/CL0768/65113.html 
H1N1 
CGMP 
Clinical 
Trials 
In 2011, China’s Ministry of Health 
adopted Good Manufacturing 
Practice (GMP) requirements1 and 
we saw another surge in letters in 
the US: 
83 letters related to Current 
Good Manufacturing Practice 
(CGMP) 
14 letters related to clinical 
investigations (failing trial 
research standards) 
28 letters for clinical investigations 
(failing trial research standards) 
33 letters were issued due to violations of 
Current Good Manufacturing Practice (CGMP) 
35 letters for products related to the H1N1 virus
2007 
0 
50 
100 
150 
200 
250 
2008 2009 2010 2011 2012 2013 
Medical Device 
FACTOR: 
Each year, we’ve seen an increase in 
consumer access to new medical 
device applications and modified 
versions of medical devices that 
do not require Premarket Approval 
(PMA) or Section 510(k) Clearances 
from the FDA.2 
1. http://www.emergogroup.com/blog/2013/05/fda-data-shows-increase-warning-letters-medical-device-firms-2005 
2. http://www.fda.gov/medicaldevices/productsandmedicalprocedures/deviceapprovalsandclearances/510kclearances/default.htm 
A steady increase in letters within the Medical Device industry resulted in the number of 
FDA-issued letters nearly 
DOUBLING 
from 2007 to 2012.1
The Food Safety Modernization 
Act signed by President Obama 
on January 4, 2011 drove a 41% 
Food & Beverage 
1. http://www.choicesmagazine.org/choices-magazine/submitted-articles/the-fdas-food-safety-modernization-act-and-its-economic-implications 
2007 
0 
50 
100 
150 
200 
250 
300 
350 
400 
2008 2009 2010 2011 2012 2013 
increase in 
letters issued to 
Food & Beverage 
companies.1
A Downward Trend in 2014 
There have been 267 Warning Letters issued in 2014 so far (as of June 30, 2014), which suggests a downward trend 
for the total amount of warning letters for the year. Among the letters received through June 2014, 44% were in the Food & Beverage industry, 26% were in the Pharma/Biotech industry, and 24% were in the Medical Device industry. 
69 
letters for 
Pharma/Biotech 
65 
letters for 
Medical Device 
117 
letters for 
Food & Beverage 
16 
letters for Consumer 
Products & Tobacco
RESEARCH BROUGHT TO YOU BY 
What’s in Store for 2015 and Beyond 
With a proposed significant budget increase for the FDA in 20151, we expect the number of warning letters to 
rise significantly for 2015 starting a new upward trend in total warning letters issued in the coming years. 
1 http://blogs.fda.gov/fdavoice/index.php/2014/03/whats-new-in-the-fdas-2015-budget/

More Related Content

What's hot

Current State of Paid Search Marketing
Current State of Paid Search MarketingCurrent State of Paid Search Marketing
Current State of Paid Search Marketing
Dale Cooke
 
FSMA Final Rule for Preventive Controls For Human Food 2015
FSMA Final Rule for Preventive Controls For Human Food 2015FSMA Final Rule for Preventive Controls For Human Food 2015
FSMA Final Rule for Preventive Controls For Human Food 2015
Asian Food Regulation Information Service
 
Pharma Quality Metrics
Pharma Quality MetricsPharma Quality Metrics
Pharma Quality Metrics
Marcep Inc.
 
Api
ApiApi
Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Alessandro Frandi
 
Active Pharmaceutical Ingredient (API); Impact of Primary / Alternate Source ...
Active Pharmaceutical Ingredient (API); Impact of Primary / Alternate Source ...Active Pharmaceutical Ingredient (API); Impact of Primary / Alternate Source ...
Active Pharmaceutical Ingredient (API); Impact of Primary / Alternate Source ...
Dr.Faheem Lakhani
 
Presentation__Reimbursement Overview
Presentation__Reimbursement OverviewPresentation__Reimbursement Overview
Presentation__Reimbursement Overview
Kendrik Lechner
 
FDA to Align with ISO 13485:2016
FDA to Align with ISO 13485:2016FDA to Align with ISO 13485:2016
FDA to Align with ISO 13485:2016
EMMAIntl
 
How to Assess New Technology - OMTEC 2017
How to Assess New Technology - OMTEC 2017How to Assess New Technology - OMTEC 2017
How to Assess New Technology - OMTEC 2017
April Bright
 
Merck: Q4 2015 Results
Merck: Q4 2015 ResultsMerck: Q4 2015 Results
Merck: Q4 2015 Results
Merck
 
The Other Agency: An introduction to Pharma Marketing
The Other Agency: An introduction to Pharma MarketingThe Other Agency: An introduction to Pharma Marketing
The Other Agency: An introduction to Pharma Marketing
Dale Cooke
 
Reliance and Recognitions (GMP Inspections)
Reliance and Recognitions (GMP Inspections)Reliance and Recognitions (GMP Inspections)
Reliance and Recognitions (GMP Inspections)
Obaid Ali / Roohi B. Obaid
 
FDA efforts to secure the pharmaceutical supply chain
FDA efforts to secure the pharmaceutical supply chainFDA efforts to secure the pharmaceutical supply chain
FDA efforts to secure the pharmaceutical supply chain
The Partnership For Safe Medicines
 
Merck & co., inc. barclays final 3-10-2015
Merck & co., inc.   barclays final 3-10-2015Merck & co., inc.   barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015
Marcel Brussee
 
Gmp 1
Gmp 1Gmp 1
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...Plan for Success Strategies to Align Reimbursement and Commercialization - OM...
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...
April Bright
 
Merck presentation.
Merck presentation.Merck presentation.
Merck presentation.
Bakryk
 
Infographic - Food and Beverage Barcode Labeling
Infographic - Food and Beverage Barcode LabelingInfographic - Food and Beverage Barcode Labeling
Infographic - Food and Beverage Barcode Labeling
Loftware
 
Bilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory OveriewBilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory Overiew
Bilcare GCS
 
NAPM Review Dec 2015
NAPM Review Dec 2015NAPM Review Dec 2015
NAPM Review Dec 2015
Student Brands
 

What's hot (20)

Current State of Paid Search Marketing
Current State of Paid Search MarketingCurrent State of Paid Search Marketing
Current State of Paid Search Marketing
 
FSMA Final Rule for Preventive Controls For Human Food 2015
FSMA Final Rule for Preventive Controls For Human Food 2015FSMA Final Rule for Preventive Controls For Human Food 2015
FSMA Final Rule for Preventive Controls For Human Food 2015
 
Pharma Quality Metrics
Pharma Quality MetricsPharma Quality Metrics
Pharma Quality Metrics
 
Api
ApiApi
Api
 
Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01
 
Active Pharmaceutical Ingredient (API); Impact of Primary / Alternate Source ...
Active Pharmaceutical Ingredient (API); Impact of Primary / Alternate Source ...Active Pharmaceutical Ingredient (API); Impact of Primary / Alternate Source ...
Active Pharmaceutical Ingredient (API); Impact of Primary / Alternate Source ...
 
Presentation__Reimbursement Overview
Presentation__Reimbursement OverviewPresentation__Reimbursement Overview
Presentation__Reimbursement Overview
 
FDA to Align with ISO 13485:2016
FDA to Align with ISO 13485:2016FDA to Align with ISO 13485:2016
FDA to Align with ISO 13485:2016
 
How to Assess New Technology - OMTEC 2017
How to Assess New Technology - OMTEC 2017How to Assess New Technology - OMTEC 2017
How to Assess New Technology - OMTEC 2017
 
Merck: Q4 2015 Results
Merck: Q4 2015 ResultsMerck: Q4 2015 Results
Merck: Q4 2015 Results
 
The Other Agency: An introduction to Pharma Marketing
The Other Agency: An introduction to Pharma MarketingThe Other Agency: An introduction to Pharma Marketing
The Other Agency: An introduction to Pharma Marketing
 
Reliance and Recognitions (GMP Inspections)
Reliance and Recognitions (GMP Inspections)Reliance and Recognitions (GMP Inspections)
Reliance and Recognitions (GMP Inspections)
 
FDA efforts to secure the pharmaceutical supply chain
FDA efforts to secure the pharmaceutical supply chainFDA efforts to secure the pharmaceutical supply chain
FDA efforts to secure the pharmaceutical supply chain
 
Merck & co., inc. barclays final 3-10-2015
Merck & co., inc.   barclays final 3-10-2015Merck & co., inc.   barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015
 
Gmp 1
Gmp 1Gmp 1
Gmp 1
 
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...Plan for Success Strategies to Align Reimbursement and Commercialization - OM...
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...
 
Merck presentation.
Merck presentation.Merck presentation.
Merck presentation.
 
Infographic - Food and Beverage Barcode Labeling
Infographic - Food and Beverage Barcode LabelingInfographic - Food and Beverage Barcode Labeling
Infographic - Food and Beverage Barcode Labeling
 
Bilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory OveriewBilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory Overiew
 
NAPM Review Dec 2015
NAPM Review Dec 2015NAPM Review Dec 2015
NAPM Review Dec 2015
 

Viewers also liked

Fiber Cable Ducting System Compare
Fiber Cable Ducting System CompareFiber Cable Ducting System Compare
Fiber Cable Ducting System Compare
Jack_Han
 
Audit Ready: Contract to Close-Out
Audit Ready: Contract to Close-OutAudit Ready: Contract to Close-Out
Audit Ready: Contract to Close-Out
Heather Kemp
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection Intelligence
Armin Torres
 
Compliance with the FDA Guidances on Investigator Responsibilities and the Fo...
Compliance with the FDA Guidances on Investigator Responsibilities and the Fo...Compliance with the FDA Guidances on Investigator Responsibilities and the Fo...
Compliance with the FDA Guidances on Investigator Responsibilities and the Fo...
Paul Below
 
4. capa industry basics - final
4. capa   industry basics - final4. capa   industry basics - final
4. capa industry basics - final
Tetali RadhaKrishna
 
FDA Audit Prep
FDA Audit PrepFDA Audit Prep
FDA Audit Prep
ClinPharm Network, Inc.
 
Inspection by regulatory authority ( fda )
Inspection by regulatory authority (  fda )Inspection by regulatory authority (  fda )
Inspection by regulatory authority ( fda )
aartipatil084
 
Leadership For The FDA Inspection The Manager Review
Leadership For The FDA Inspection   The Manager ReviewLeadership For The FDA Inspection   The Manager Review
Leadership For The FDA Inspection The Manager Review
Mitchell Manning Sr.
 
3 top ten fda warning letter findings by the
3 top ten fda warning letter findings by the3 top ten fda warning letter findings by the
3 top ten fda warning letter findings by the
Shirley Roach
 
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersHow to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
Greenlight Guru
 
FDA Inspection
FDA InspectionFDA Inspection
Audits & Inspections in Clinical Research
Audits & Inspections in Clinical ResearchAudits & Inspections in Clinical Research
Audits & Inspections in Clinical Research
Jobin Kunjumon Vilapurathuu
 
Corrective and preventive action plan CAPA report form
Corrective and preventive action plan  CAPA report formCorrective and preventive action plan  CAPA report form
Corrective and preventive action plan CAPA report form
Connie Dello Buono
 
FDA PreApproval Inspection - Part 2
FDA PreApproval Inspection - Part 2FDA PreApproval Inspection - Part 2
FDA PreApproval Inspection - Part 2
Jorge Torres
 
HVAC SYSTEM IN PHARMACEUTICAL INDUSTRY
HVAC SYSTEM IN PHARMACEUTICAL INDUSTRYHVAC SYSTEM IN PHARMACEUTICAL INDUSTRY
HVAC SYSTEM IN PHARMACEUTICAL INDUSTRY
Namdeo Shinde
 
CAPA, Root Cause Analysis and Risk Management
CAPA, Root Cause Analysis and Risk ManagementCAPA, Root Cause Analysis and Risk Management
CAPA, Root Cause Analysis and Risk Management
Joseph Tarsio
 
Root Cause Analysis Presentation
Root Cause Analysis PresentationRoot Cause Analysis Presentation
pharmaceutical clean room
pharmaceutical clean room pharmaceutical clean room
pharmaceutical clean room
Kiran Thakur
 
Monitoring and auditing in clinical trials
Monitoring and auditing in clinical trialsMonitoring and auditing in clinical trials
Monitoring and auditing in clinical trials
Jyotsna Kapoor
 

Viewers also liked (19)

Fiber Cable Ducting System Compare
Fiber Cable Ducting System CompareFiber Cable Ducting System Compare
Fiber Cable Ducting System Compare
 
Audit Ready: Contract to Close-Out
Audit Ready: Contract to Close-OutAudit Ready: Contract to Close-Out
Audit Ready: Contract to Close-Out
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection Intelligence
 
Compliance with the FDA Guidances on Investigator Responsibilities and the Fo...
Compliance with the FDA Guidances on Investigator Responsibilities and the Fo...Compliance with the FDA Guidances on Investigator Responsibilities and the Fo...
Compliance with the FDA Guidances on Investigator Responsibilities and the Fo...
 
4. capa industry basics - final
4. capa   industry basics - final4. capa   industry basics - final
4. capa industry basics - final
 
FDA Audit Prep
FDA Audit PrepFDA Audit Prep
FDA Audit Prep
 
Inspection by regulatory authority ( fda )
Inspection by regulatory authority (  fda )Inspection by regulatory authority (  fda )
Inspection by regulatory authority ( fda )
 
Leadership For The FDA Inspection The Manager Review
Leadership For The FDA Inspection   The Manager ReviewLeadership For The FDA Inspection   The Manager Review
Leadership For The FDA Inspection The Manager Review
 
3 top ten fda warning letter findings by the
3 top ten fda warning letter findings by the3 top ten fda warning letter findings by the
3 top ten fda warning letter findings by the
 
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersHow to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
 
FDA Inspection
FDA InspectionFDA Inspection
FDA Inspection
 
Audits & Inspections in Clinical Research
Audits & Inspections in Clinical ResearchAudits & Inspections in Clinical Research
Audits & Inspections in Clinical Research
 
Corrective and preventive action plan CAPA report form
Corrective and preventive action plan  CAPA report formCorrective and preventive action plan  CAPA report form
Corrective and preventive action plan CAPA report form
 
FDA PreApproval Inspection - Part 2
FDA PreApproval Inspection - Part 2FDA PreApproval Inspection - Part 2
FDA PreApproval Inspection - Part 2
 
HVAC SYSTEM IN PHARMACEUTICAL INDUSTRY
HVAC SYSTEM IN PHARMACEUTICAL INDUSTRYHVAC SYSTEM IN PHARMACEUTICAL INDUSTRY
HVAC SYSTEM IN PHARMACEUTICAL INDUSTRY
 
CAPA, Root Cause Analysis and Risk Management
CAPA, Root Cause Analysis and Risk ManagementCAPA, Root Cause Analysis and Risk Management
CAPA, Root Cause Analysis and Risk Management
 
Root Cause Analysis Presentation
Root Cause Analysis PresentationRoot Cause Analysis Presentation
Root Cause Analysis Presentation
 
pharmaceutical clean room
pharmaceutical clean room pharmaceutical clean room
pharmaceutical clean room
 
Monitoring and auditing in clinical trials
Monitoring and auditing in clinical trialsMonitoring and auditing in clinical trials
Monitoring and auditing in clinical trials
 

Similar to FDA Warning Letters Study

Medical Instrument and Supply Manufacturing Industry Report
Medical Instrument and Supply Manufacturing Industry ReportMedical Instrument and Supply Manufacturing Industry Report
Medical Instrument and Supply Manufacturing Industry Report
Charles Pontrelli
 
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014
Will Zasadny
 
Real World Evidence in the MedTech Industry
Real World Evidence in the MedTech IndustryReal World Evidence in the MedTech Industry
Real World Evidence in the MedTech Industry
EMMAIntl
 
Business Research Project-Report
Business Research Project-ReportBusiness Research Project-Report
Business Research Project-Report
Sharil Rose
 
Fda communications-oversight-in-a-digital-era
Fda communications-oversight-in-a-digital-eraFda communications-oversight-in-a-digital-era
Fda communications-oversight-in-a-digital-era
Freedom Monk
 
Food Safety Regulation
Food Safety RegulationFood Safety Regulation
Food Safety Regulation
Jess Jacobs
 
The Clinical Trials Business
The Clinical Trials BusinessThe Clinical Trials Business
The Clinical Trials Business
ReportLinker.com
 
The Economic Impact Of Medical Tourism
The Economic Impact Of Medical TourismThe Economic Impact Of Medical Tourism
The Economic Impact Of Medical Tourism
David Vequist
 
Mercer Capital's Value Focus: Laboratory Services | Mid-Year 2015
Mercer Capital's Value Focus: Laboratory Services | Mid-Year 2015Mercer Capital's Value Focus: Laboratory Services | Mid-Year 2015
Mercer Capital's Value Focus: Laboratory Services | Mid-Year 2015
Mercer Capital
 
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015
Sathish Vemula
 
Is Pharma Drug Pricing Being Disrupted?
Is Pharma Drug Pricing Being Disrupted?Is Pharma Drug Pricing Being Disrupted?
Is Pharma Drug Pricing Being Disrupted?
IFAH
 
Strategic alternatives
Strategic alternativesStrategic alternatives
Strategic alternatives
esharma_86
 
The value of early asset development and commercialization
The value of early asset development and commercializationThe value of early asset development and commercialization
The value of early asset development and commercialization
Cello Health
 
Newtech advant-business-plan9
Newtech advant-business-plan9Newtech advant-business-plan9
Newtech advant-business-plan9
Yousaf Khan
 
99580907 global-cro-report
99580907 global-cro-report99580907 global-cro-report
99580907 global-cro-report
patyi_2000
 
FDA Promotes Transparency, Collaboration for 2018
FDA Promotes Transparency, Collaboration for 2018FDA Promotes Transparency, Collaboration for 2018
FDA Promotes Transparency, Collaboration for 2018
Georgia_Bull
 
Mera medicare
Mera medicareMera medicare
Mera medicare
RAHUL2014-2016
 
biotech
biotechbiotech
Understanding Food & Drug Recalls
Understanding Food & Drug RecallsUnderstanding Food & Drug Recalls
Understanding Food & Drug Recalls
Celeritech International
 
Unique Device Identification and GS1: Defining Elements in the Future of Glob...
Unique Device Identification and GS1: Defining Elements in the Future of Glob...Unique Device Identification and GS1: Defining Elements in the Future of Glob...
Unique Device Identification and GS1: Defining Elements in the Future of Glob...
Loftware
 

Similar to FDA Warning Letters Study (20)

Medical Instrument and Supply Manufacturing Industry Report
Medical Instrument and Supply Manufacturing Industry ReportMedical Instrument and Supply Manufacturing Industry Report
Medical Instrument and Supply Manufacturing Industry Report
 
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014
 
Real World Evidence in the MedTech Industry
Real World Evidence in the MedTech IndustryReal World Evidence in the MedTech Industry
Real World Evidence in the MedTech Industry
 
Business Research Project-Report
Business Research Project-ReportBusiness Research Project-Report
Business Research Project-Report
 
Fda communications-oversight-in-a-digital-era
Fda communications-oversight-in-a-digital-eraFda communications-oversight-in-a-digital-era
Fda communications-oversight-in-a-digital-era
 
Food Safety Regulation
Food Safety RegulationFood Safety Regulation
Food Safety Regulation
 
The Clinical Trials Business
The Clinical Trials BusinessThe Clinical Trials Business
The Clinical Trials Business
 
The Economic Impact Of Medical Tourism
The Economic Impact Of Medical TourismThe Economic Impact Of Medical Tourism
The Economic Impact Of Medical Tourism
 
Mercer Capital's Value Focus: Laboratory Services | Mid-Year 2015
Mercer Capital's Value Focus: Laboratory Services | Mid-Year 2015Mercer Capital's Value Focus: Laboratory Services | Mid-Year 2015
Mercer Capital's Value Focus: Laboratory Services | Mid-Year 2015
 
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015
 
Is Pharma Drug Pricing Being Disrupted?
Is Pharma Drug Pricing Being Disrupted?Is Pharma Drug Pricing Being Disrupted?
Is Pharma Drug Pricing Being Disrupted?
 
Strategic alternatives
Strategic alternativesStrategic alternatives
Strategic alternatives
 
The value of early asset development and commercialization
The value of early asset development and commercializationThe value of early asset development and commercialization
The value of early asset development and commercialization
 
Newtech advant-business-plan9
Newtech advant-business-plan9Newtech advant-business-plan9
Newtech advant-business-plan9
 
99580907 global-cro-report
99580907 global-cro-report99580907 global-cro-report
99580907 global-cro-report
 
FDA Promotes Transparency, Collaboration for 2018
FDA Promotes Transparency, Collaboration for 2018FDA Promotes Transparency, Collaboration for 2018
FDA Promotes Transparency, Collaboration for 2018
 
Mera medicare
Mera medicareMera medicare
Mera medicare
 
biotech
biotechbiotech
biotech
 
Understanding Food & Drug Recalls
Understanding Food & Drug RecallsUnderstanding Food & Drug Recalls
Understanding Food & Drug Recalls
 
Unique Device Identification and GS1: Defining Elements in the Future of Glob...
Unique Device Identification and GS1: Defining Elements in the Future of Glob...Unique Device Identification and GS1: Defining Elements in the Future of Glob...
Unique Device Identification and GS1: Defining Elements in the Future of Glob...
 

More from Sparta Systems

Webinar SQM Best Practices and Insights
Webinar SQM Best Practices and InsightsWebinar SQM Best Practices and Insights
Webinar SQM Best Practices and Insights
Sparta Systems
 
Managing the Supply Chain with TrackWise
Managing the Supply Chain with TrackWise Managing the Supply Chain with TrackWise
Managing the Supply Chain with TrackWise
Sparta Systems
 
Building In & Out
Building In & OutBuilding In & Out
Building In & Out
Sparta Systems
 
TrackWise: Enterprise Quality Management-Lösung (EQMS) für die Pharma- und Bi...
TrackWise: Enterprise Quality Management-Lösung (EQMS) für die Pharma- und Bi...TrackWise: Enterprise Quality Management-Lösung (EQMS) für die Pharma- und Bi...
TrackWise: Enterprise Quality Management-Lösung (EQMS) für die Pharma- und Bi...
Sparta Systems
 
Your Best Recall is the One You Never Have to Do
Your Best Recall is the One You Never Have to DoYour Best Recall is the One You Never Have to Do
Your Best Recall is the One You Never Have to Do
Sparta Systems
 
Cloud Technology and Its Implication for Quality Services
Cloud Technology and Its Implication for Quality ServicesCloud Technology and Its Implication for Quality Services
Cloud Technology and Its Implication for Quality Services
Sparta Systems
 
Understanding Enterprise Quality Management Systems (EQMS)
Understanding Enterprise Quality Management Systems (EQMS)Understanding Enterprise Quality Management Systems (EQMS)
Understanding Enterprise Quality Management Systems (EQMS)
Sparta Systems
 
Creating the Case for Enterprise Quality
Creating the Case for Enterprise QualityCreating the Case for Enterprise Quality
Creating the Case for Enterprise Quality
Sparta Systems
 

More from Sparta Systems (8)

Webinar SQM Best Practices and Insights
Webinar SQM Best Practices and InsightsWebinar SQM Best Practices and Insights
Webinar SQM Best Practices and Insights
 
Managing the Supply Chain with TrackWise
Managing the Supply Chain with TrackWise Managing the Supply Chain with TrackWise
Managing the Supply Chain with TrackWise
 
Building In & Out
Building In & OutBuilding In & Out
Building In & Out
 
TrackWise: Enterprise Quality Management-Lösung (EQMS) für die Pharma- und Bi...
TrackWise: Enterprise Quality Management-Lösung (EQMS) für die Pharma- und Bi...TrackWise: Enterprise Quality Management-Lösung (EQMS) für die Pharma- und Bi...
TrackWise: Enterprise Quality Management-Lösung (EQMS) für die Pharma- und Bi...
 
Your Best Recall is the One You Never Have to Do
Your Best Recall is the One You Never Have to DoYour Best Recall is the One You Never Have to Do
Your Best Recall is the One You Never Have to Do
 
Cloud Technology and Its Implication for Quality Services
Cloud Technology and Its Implication for Quality ServicesCloud Technology and Its Implication for Quality Services
Cloud Technology and Its Implication for Quality Services
 
Understanding Enterprise Quality Management Systems (EQMS)
Understanding Enterprise Quality Management Systems (EQMS)Understanding Enterprise Quality Management Systems (EQMS)
Understanding Enterprise Quality Management Systems (EQMS)
 
Creating the Case for Enterprise Quality
Creating the Case for Enterprise QualityCreating the Case for Enterprise Quality
Creating the Case for Enterprise Quality
 

Recently uploaded

Atelier - Innover avec l’IA Générative et les graphes de connaissances
Atelier - Innover avec l’IA Générative et les graphes de connaissancesAtelier - Innover avec l’IA Générative et les graphes de connaissances
Atelier - Innover avec l’IA Générative et les graphes de connaissances
Neo4j
 
KuberTENes Birthday Bash Guadalajara - Introducción a Argo CD
KuberTENes Birthday Bash Guadalajara - Introducción a Argo CDKuberTENes Birthday Bash Guadalajara - Introducción a Argo CD
KuberTENes Birthday Bash Guadalajara - Introducción a Argo CD
rodomar2
 
Energy consumption of Database Management - Florina Jonuzi
Energy consumption of Database Management - Florina JonuziEnergy consumption of Database Management - Florina Jonuzi
Energy consumption of Database Management - Florina Jonuzi
Green Software Development
 
Automated software refactoring with OpenRewrite and Generative AI.pptx.pdf
Automated software refactoring with OpenRewrite and Generative AI.pptx.pdfAutomated software refactoring with OpenRewrite and Generative AI.pptx.pdf
Automated software refactoring with OpenRewrite and Generative AI.pptx.pdf
timtebeek1
 
Hand Rolled Applicative User Validation Code Kata
Hand Rolled Applicative User ValidationCode KataHand Rolled Applicative User ValidationCode Kata
Hand Rolled Applicative User Validation Code Kata
Philip Schwarz
 
Oracle Database 19c New Features for DBAs and Developers.pptx
Oracle Database 19c New Features for DBAs and Developers.pptxOracle Database 19c New Features for DBAs and Developers.pptx
Oracle Database 19c New Features for DBAs and Developers.pptx
Remote DBA Services
 
openEuler Case Study - The Journey to Supply Chain Security
openEuler Case Study - The Journey to Supply Chain SecurityopenEuler Case Study - The Journey to Supply Chain Security
openEuler Case Study - The Journey to Supply Chain Security
Shane Coughlan
 
A Study of Variable-Role-based Feature Enrichment in Neural Models of Code
A Study of Variable-Role-based Feature Enrichment in Neural Models of CodeA Study of Variable-Role-based Feature Enrichment in Neural Models of Code
A Study of Variable-Role-based Feature Enrichment in Neural Models of Code
Aftab Hussain
 
What is Augmented Reality Image Tracking
What is Augmented Reality Image TrackingWhat is Augmented Reality Image Tracking
What is Augmented Reality Image Tracking
pavan998932
 
May Marketo Masterclass, London MUG May 22 2024.pdf
May Marketo Masterclass, London MUG May 22 2024.pdfMay Marketo Masterclass, London MUG May 22 2024.pdf
May Marketo Masterclass, London MUG May 22 2024.pdf
Adele Miller
 
GreenCode-A-VSCode-Plugin--Dario-Jurisic
GreenCode-A-VSCode-Plugin--Dario-JurisicGreenCode-A-VSCode-Plugin--Dario-Jurisic
GreenCode-A-VSCode-Plugin--Dario-Jurisic
Green Software Development
 
Revolutionizing Visual Effects Mastering AI Face Swaps.pdf
Revolutionizing Visual Effects Mastering AI Face Swaps.pdfRevolutionizing Visual Effects Mastering AI Face Swaps.pdf
Revolutionizing Visual Effects Mastering AI Face Swaps.pdf
Undress Baby
 
Neo4j - Product Vision and Knowledge Graphs - GraphSummit Paris
Neo4j - Product Vision and Knowledge Graphs - GraphSummit ParisNeo4j - Product Vision and Knowledge Graphs - GraphSummit Paris
Neo4j - Product Vision and Knowledge Graphs - GraphSummit Paris
Neo4j
 
Microservice Teams - How the cloud changes the way we work
Microservice Teams - How the cloud changes the way we workMicroservice Teams - How the cloud changes the way we work
Microservice Teams - How the cloud changes the way we work
Sven Peters
 
ALGIT - Assembly Line for Green IT - Numbers, Data, Facts
ALGIT - Assembly Line for Green IT - Numbers, Data, FactsALGIT - Assembly Line for Green IT - Numbers, Data, Facts
ALGIT - Assembly Line for Green IT - Numbers, Data, Facts
Green Software Development
 
OpenMetadata Community Meeting - 5th June 2024
OpenMetadata Community Meeting - 5th June 2024OpenMetadata Community Meeting - 5th June 2024
OpenMetadata Community Meeting - 5th June 2024
OpenMetadata
 
APIs for Browser Automation (MoT Meetup 2024)
APIs for Browser Automation (MoT Meetup 2024)APIs for Browser Automation (MoT Meetup 2024)
APIs for Browser Automation (MoT Meetup 2024)
Boni García
 
GraphSummit Paris - The art of the possible with Graph Technology
GraphSummit Paris - The art of the possible with Graph TechnologyGraphSummit Paris - The art of the possible with Graph Technology
GraphSummit Paris - The art of the possible with Graph Technology
Neo4j
 
Orion Context Broker introduction 20240604
Orion Context Broker introduction 20240604Orion Context Broker introduction 20240604
Orion Context Broker introduction 20240604
Fermin Galan
 
Introducing Crescat - Event Management Software for Venues, Festivals and Eve...
Introducing Crescat - Event Management Software for Venues, Festivals and Eve...Introducing Crescat - Event Management Software for Venues, Festivals and Eve...
Introducing Crescat - Event Management Software for Venues, Festivals and Eve...
Crescat
 

Recently uploaded (20)

Atelier - Innover avec l’IA Générative et les graphes de connaissances
Atelier - Innover avec l’IA Générative et les graphes de connaissancesAtelier - Innover avec l’IA Générative et les graphes de connaissances
Atelier - Innover avec l’IA Générative et les graphes de connaissances
 
KuberTENes Birthday Bash Guadalajara - Introducción a Argo CD
KuberTENes Birthday Bash Guadalajara - Introducción a Argo CDKuberTENes Birthday Bash Guadalajara - Introducción a Argo CD
KuberTENes Birthday Bash Guadalajara - Introducción a Argo CD
 
Energy consumption of Database Management - Florina Jonuzi
Energy consumption of Database Management - Florina JonuziEnergy consumption of Database Management - Florina Jonuzi
Energy consumption of Database Management - Florina Jonuzi
 
Automated software refactoring with OpenRewrite and Generative AI.pptx.pdf
Automated software refactoring with OpenRewrite and Generative AI.pptx.pdfAutomated software refactoring with OpenRewrite and Generative AI.pptx.pdf
Automated software refactoring with OpenRewrite and Generative AI.pptx.pdf
 
Hand Rolled Applicative User Validation Code Kata
Hand Rolled Applicative User ValidationCode KataHand Rolled Applicative User ValidationCode Kata
Hand Rolled Applicative User Validation Code Kata
 
Oracle Database 19c New Features for DBAs and Developers.pptx
Oracle Database 19c New Features for DBAs and Developers.pptxOracle Database 19c New Features for DBAs and Developers.pptx
Oracle Database 19c New Features for DBAs and Developers.pptx
 
openEuler Case Study - The Journey to Supply Chain Security
openEuler Case Study - The Journey to Supply Chain SecurityopenEuler Case Study - The Journey to Supply Chain Security
openEuler Case Study - The Journey to Supply Chain Security
 
A Study of Variable-Role-based Feature Enrichment in Neural Models of Code
A Study of Variable-Role-based Feature Enrichment in Neural Models of CodeA Study of Variable-Role-based Feature Enrichment in Neural Models of Code
A Study of Variable-Role-based Feature Enrichment in Neural Models of Code
 
What is Augmented Reality Image Tracking
What is Augmented Reality Image TrackingWhat is Augmented Reality Image Tracking
What is Augmented Reality Image Tracking
 
May Marketo Masterclass, London MUG May 22 2024.pdf
May Marketo Masterclass, London MUG May 22 2024.pdfMay Marketo Masterclass, London MUG May 22 2024.pdf
May Marketo Masterclass, London MUG May 22 2024.pdf
 
GreenCode-A-VSCode-Plugin--Dario-Jurisic
GreenCode-A-VSCode-Plugin--Dario-JurisicGreenCode-A-VSCode-Plugin--Dario-Jurisic
GreenCode-A-VSCode-Plugin--Dario-Jurisic
 
Revolutionizing Visual Effects Mastering AI Face Swaps.pdf
Revolutionizing Visual Effects Mastering AI Face Swaps.pdfRevolutionizing Visual Effects Mastering AI Face Swaps.pdf
Revolutionizing Visual Effects Mastering AI Face Swaps.pdf
 
Neo4j - Product Vision and Knowledge Graphs - GraphSummit Paris
Neo4j - Product Vision and Knowledge Graphs - GraphSummit ParisNeo4j - Product Vision and Knowledge Graphs - GraphSummit Paris
Neo4j - Product Vision and Knowledge Graphs - GraphSummit Paris
 
Microservice Teams - How the cloud changes the way we work
Microservice Teams - How the cloud changes the way we workMicroservice Teams - How the cloud changes the way we work
Microservice Teams - How the cloud changes the way we work
 
ALGIT - Assembly Line for Green IT - Numbers, Data, Facts
ALGIT - Assembly Line for Green IT - Numbers, Data, FactsALGIT - Assembly Line for Green IT - Numbers, Data, Facts
ALGIT - Assembly Line for Green IT - Numbers, Data, Facts
 
OpenMetadata Community Meeting - 5th June 2024
OpenMetadata Community Meeting - 5th June 2024OpenMetadata Community Meeting - 5th June 2024
OpenMetadata Community Meeting - 5th June 2024
 
APIs for Browser Automation (MoT Meetup 2024)
APIs for Browser Automation (MoT Meetup 2024)APIs for Browser Automation (MoT Meetup 2024)
APIs for Browser Automation (MoT Meetup 2024)
 
GraphSummit Paris - The art of the possible with Graph Technology
GraphSummit Paris - The art of the possible with Graph TechnologyGraphSummit Paris - The art of the possible with Graph Technology
GraphSummit Paris - The art of the possible with Graph Technology
 
Orion Context Broker introduction 20240604
Orion Context Broker introduction 20240604Orion Context Broker introduction 20240604
Orion Context Broker introduction 20240604
 
Introducing Crescat - Event Management Software for Venues, Festivals and Eve...
Introducing Crescat - Event Management Software for Venues, Festivals and Eve...Introducing Crescat - Event Management Software for Venues, Festivals and Eve...
Introducing Crescat - Event Management Software for Venues, Festivals and Eve...
 

FDA Warning Letters Study

  • 1. FDA Warning Letters Study A Look at Warning Letters for Pharma/Biotech, Medical Device, and Food & Beverage Industries Since 2007 A Warning Letter is official correspondence that notifies the highest-ranking known official of a regulated company that a serious violation of organizational regulations has been committed. These letters are published on the FDA website and are available for review by other government agencies, businesses, consumers, and the media.
  • 2. FDA Warning Letters Issued by Year The average growth rate for warning letters issued between 2007 and 2012 was 15.8% per year. The issuing of FDA Warning Letters increased 78% from 2007 to 2013, even with a 12.4% decrease from 2012 to 2013. 2007–2012 We wanted to understand: What industries contributed the most to the increase and why? 2012–June 30, 2014 We believe the decrease was due to fewer FDA inspections as a result of reduced funding for the FDA1 and an industry-wide freeze on manufacturers’ FDA fees. 1. http://www.politico.com/story/2013/02/fda-commissioner-margaret-hamburg-2013-budget-cuts-mean-less-safe-food-88241.html 27.5% Decreased by comparing the first 6 months of 2013 to the first 6 months of 2014 12.4% Decreased by from 2012 to 2013 104% Total increase of from 2007 to 2012 Increased by an average of per year (2007 to 2012) 15.8%
  • 3. Since FDA warning letters are made available to the public, we did some digging to find which industries accounted for the highest number of warning letters. Three industries comprised 95.72% of all FDA warning letters that were received between 2007 and 2013. Pharmaceutical/Biotechnology Medical Device Food & Beverage Industry Comparison Tobacco Consumer Products Pharmaceutical/ Biotechnology Food & Beverage Medical Device
  • 4. In 2009, FDA warning letters to Pharma/Biotech companies increased by 48.59%. The following areas accounted for the increase (actual numbers): Pharmaceutical/ Biotechnology 2007 0 50 100 150 200 250 2008 2009 2010 2011 2012 2013 1. http://eng.sfda.gov.cn/WS03/CL0768/65113.html H1N1 CGMP Clinical Trials In 2011, China’s Ministry of Health adopted Good Manufacturing Practice (GMP) requirements1 and we saw another surge in letters in the US: 83 letters related to Current Good Manufacturing Practice (CGMP) 14 letters related to clinical investigations (failing trial research standards) 28 letters for clinical investigations (failing trial research standards) 33 letters were issued due to violations of Current Good Manufacturing Practice (CGMP) 35 letters for products related to the H1N1 virus
  • 5. 2007 0 50 100 150 200 250 2008 2009 2010 2011 2012 2013 Medical Device FACTOR: Each year, we’ve seen an increase in consumer access to new medical device applications and modified versions of medical devices that do not require Premarket Approval (PMA) or Section 510(k) Clearances from the FDA.2 1. http://www.emergogroup.com/blog/2013/05/fda-data-shows-increase-warning-letters-medical-device-firms-2005 2. http://www.fda.gov/medicaldevices/productsandmedicalprocedures/deviceapprovalsandclearances/510kclearances/default.htm A steady increase in letters within the Medical Device industry resulted in the number of FDA-issued letters nearly DOUBLING from 2007 to 2012.1
  • 6. The Food Safety Modernization Act signed by President Obama on January 4, 2011 drove a 41% Food & Beverage 1. http://www.choicesmagazine.org/choices-magazine/submitted-articles/the-fdas-food-safety-modernization-act-and-its-economic-implications 2007 0 50 100 150 200 250 300 350 400 2008 2009 2010 2011 2012 2013 increase in letters issued to Food & Beverage companies.1
  • 7. A Downward Trend in 2014 There have been 267 Warning Letters issued in 2014 so far (as of June 30, 2014), which suggests a downward trend for the total amount of warning letters for the year. Among the letters received through June 2014, 44% were in the Food & Beverage industry, 26% were in the Pharma/Biotech industry, and 24% were in the Medical Device industry. 69 letters for Pharma/Biotech 65 letters for Medical Device 117 letters for Food & Beverage 16 letters for Consumer Products & Tobacco
  • 8. RESEARCH BROUGHT TO YOU BY What’s in Store for 2015 and Beyond With a proposed significant budget increase for the FDA in 20151, we expect the number of warning letters to rise significantly for 2015 starting a new upward trend in total warning letters issued in the coming years. 1 http://blogs.fda.gov/fdavoice/index.php/2014/03/whats-new-in-the-fdas-2015-budget/